日本的近紅外線成像市場評估:產品·用途·終端用戶·各地區的機會及預測 (2018-2032年)

日本近紅外線成像市場規模預計將從 2024 年的 1.1609 億美元增長到 2032 年的 1.8006 億美元，預測期內的複合年增長率為 5.64%。由於癌症、心血管疾病和神經系統疾病等慢性疾病的發病率不斷上升，以及對先進成像技術的需求不斷增加，預計日本近紅外線成像市場將在預測期內實現強勁增長。

近紅外線成像是一種不可見成像技術，利用近紅外光觀察組織和物體內部的結構功能和活動。先進的影像解決方案可以改善診斷和治療結果。人工智慧和先進螢光劑的加入等技術發展幾乎提高了紅外線以外視覺化系統的性能，使其得以在各種醫療保健應用中實施。此外，近紅外線成像在微創和影像導引手術（尤其是腫瘤學和重建手術）中的應用越來越多，正在推動市場成長。例如，2024年3月，Artience株式會社推出了Sciforiem FI系列，這是一種先進的近紅外線螢光探針，可用於對細胞和外泌體進行高靈敏度成像。這些探針具有快速、生動的染色、高螢光強度和優異的光穩定性。

本報告提供日本的近紅外線成像的市場調查，彙整市場定義和概要，市場規模的轉變·預測，各種區分的詳細分析，影響市場成長因素的分析，案例研究，競爭情形，主要企業簡介等資訊。

目錄

第1章 計劃的範圍和定義

第2章 調查手法

第3章 摘要整理

第4章 日本的近紅外線成像市場展望

• 市場規模的分析·預測
• 市場佔有率的分析·預測
  • 各產品
  • 各用途
  • 各終端用戶
  • 各地區
  • 企業佔有率分析(前五名公司以及其他)
• 市場地圖分析

第5章 供需分析

第6章 價值鏈分析

第7章 波特的五力分析

第8章 大環境分析

第9章 價格分析

第10章 市場動態

• 推動市場要素
• 市場課題

第11章 市場趨勢·展開

第12章 法規結構和革新

• 法規當局的認證
• 革新

第13章 專利的形勢

第14章 案例研究

第15章 競爭情形

• 前五名公司的競爭矩陣
• 前五名公司的SWOT分析
• 前十大企業的形勢
  • Carl Zeiss Meditec AG
  • Shimadzu Corporation
  • Stryker Corporation.
  • Olympus Corporation.
  • Hamamatsu Photonics K.K.
  • Medtronic plc

第16章 策略性建議

第17章 關於調查公司·免責聲明

Japan near-infrared imaging (NIR) market is projected to witness a CAGR of 5.64% during the forecast period FY2025-FY2032, growing from USD 116.09 million in FY2024 to USD 180.06 million in FY2032. The near-infrared imaging market in Japan is expected to grow robustly during the forecast period owing to the rising prevalence of chronic diseases, such as cancer, cardiovascular conditions, and neurological disorders, and increased demand for advanced imaging technologies.

Near-infrared imaging is an invisible imaging technique that uses near-infrared light to view the structural function and activity inside the tissue or objects. Moreover, advanced imaging solutions can improve diagnostic and treatment outcomes. With technological developments such as artificial intelligence and the addition of advanced fluorescent agents, the performance of the visualization system is almost improved in infrared form, and implementation in various healthcare applications is supplied. Additionally, the increased utilization of NIR imaging in minimally invasive and image-guided surgeries, especially in oncology and reconstructive procedures, is driving market growth. For instance, in March 2024, Artience Co., Ltd. announced the Sciforiem FI Series, advanced near-infrared fluorescence probes, for high-sensitivity imaging of cells and exosomes. These probes offer fast, vivid staining, high fluorescence intensity, and superior photostability.

Rising Demand for Non-Invasive Diagnostics for Chronic and Age-Related Diseases

The growing demand for non-invasive diagnostic solutions for treating chronic and age-related diseases is a key driver for the growth of the near-infrared imaging market in Japan. Japan's aging population leads to an increase in the prevalence of diseases such as cancer, cardiovascular diseases, and neurological disorders, thereby increasing the need for advanced imaging technologies that provide accurate real-time information without the risks associated with invasive procedures. NIR imaging's ability to visualize biological tissues safely, painlessly, and in detail makes it an attractive option for early diagnosis and monitoring, facilitating easy implementation in clinical and research settings. This trend is expected to continue to drive market expansion as healthcare providers favor patient-centric, minimally invasive diagnostic approaches. For instance, a study published in the Anticancer Research Journal evaluated the feasibility of combining near-infrared photoimmunotherapy with immune checkpoint inhibitor therapy for unresectable recurrent head and neck cancer. Conducted at Ryukyu University Hospital, the study included five patients, four of whom received NIR-PIT combined with pembrolizumab. A 100% best-observed response rate was achieved among seven treated lesions, with three complete and four partial responses.

Advancements in Imaging Technologies Drive Market Growth

Advances in imaging technologies are major growth drivers for the Japan near-infrared imaging market. Incorporating cutting-edge innovations such as artificial intelligence, improved fluorescence agents, and high-resolution sensors greatly enhanced NIR imaging systems' accuracy, sensitivity, and real-time capabilities. Technological advances allow for more accurate diagnostics, especially in complex medical applications such as oncology, neurology, and cardiovascular imaging. Portable and low-cost solutions for NIR imaging are bringing the market within the reach of different settings, including hospitals and point-of-care facilities. Therefore, the prospects of this technology further improve the demands for NIR imaging as the advancement in imaging technology progresses. For instance, in October 2024, e-con Systems Inc. launched the See3CAM_CU83, a 4K RGB-IR superspeed USB camera featuring onsemi's AR0830 sensor. This innovative camera captures both RGB and infrared images simultaneously, making it suitable for various applications such as biometric access control, in-cabin monitoring, crop health monitoring, image-guided surgeries, and smart patient monitoring.

Near-Infrared Devices Segment to Dominate the Near-Infrared Imaging Market

The near-infrared devices segment is expected to capture the maximum market share in the near-infrared imaging market, led by extensive use across sectors such as health care, manufacturing, and agriculture, which can make this possible. It is encompassed by cameras, sensors, and even systems with high-quality capabilities in real-time analysis, non-invasive diagnostics, and material inspection. Its applications in health care are highly in demand nowadays as a better diagnostic tool for chronic diseases and surgical guidance. Meanwhile, industries use NIR devices for quality control and defect control. Ongoing technological advancements in this segment, including improved sensitivity and portability, are expected to maintain market leadership and will continue contributing to market growth. For instance, in August 2024, Shimadzu Corporation launched the LuminousQuester NI, a near-infrared imaging system designed to enhance drug discovery research. This system features a camera that simultaneously captures near-infrared and visible light and dedicated software for nonclinical applications.

Preclinical Imaging Segment to Dominate the Near-Infrared Imaging Market

The preclinical imaging segment is expected to dominate the Japan near-infrared imaging market, with rising demand for advanced imaging solutions primarily in drug discovery, disease modeling, and preclinical research expected to drive market growth. Near-infrared imaging is a high-resolution, non-invasive, real-time technique for visualizing biological processes. As such, they play an important role in early-stage research for evaluating treatment efficacy and monitoring disease progression. Their high sensitivity and specificity in tracking molecular and cellular activity enhance their utility in preclinical research, especially in the areas of oncology, neurology, and cardiovascular research. The demand for efficient and accurate preclinical imaging technologies, especially with pharmaceutical and biotechnology companies continuing to focus on developing novel therapeutics, will propel significant growth in this segment. For instance, in October 2021, MILabs B.V. introduced its 7 Series Integrated Line of products, enhancing user experience by improving the performance of individual imaging modalities and their integration. The new system reveals molecular images previously obscured by noise, enabling advanced applications such as SPECT to PET translation, fluorescence and bioluminescence tomography, and targeted radiotherapy with high-energy tracers.

Future Market Scenario (FY2025-FY2032F)

Continuous innovations in miniaturized, high-resolution NIR imaging systems will push the adoption of these applications into medical, industrial, and scientific use.

Growing usage in healthcare, food inspection, environmental monitoring, and semiconductor testing is going to open up wider markets.

The demand for NIR imaging in medical applications like tissue imaging and surgical guidance is increasing due to the increased needs of healthcare, which are driven by the aging population and by a focus on precision diagnostics.

Strong governmental support and investments in research and development are fostering innovation and market growth.

The market is going to be more competitive in nature, where the focus will be on product differentiation, customization, and localized solutions to meet industry-specific demands.

Key Players Landscape and Outlook

Japan near-infrared imaging market is shaped by strategic initiatives such as mergers, acquisitions, and collaborations among key players, driving innovation and growth. Regulatory approvals for new products further enhance market expansion, positioning NIR imaging for continued development and increased adoption across various sectors.

For instance, in February 2024, Hamamatsu Photonics K.K. introduced the C16741-40U, a high-performance InGaAs camera with sensitivity from 400 nm to 1700 nm, spanning visible to SWIR regions. Due to minimized readout noise, it delivers high-resolution imaging with an exceptional signal-to-noise ratio. Integrated Peltier cooling ensures sensor stability, while the USB 3.1 Gen 1 interface supports 12-bit imaging and adjustable exposure times. Designed for food sorting, plastic recycling, silicon wafer inspection, laser alignment, and solar cell evaluation.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Japan Near-Infrared Imaging Market Outlook, FY2018-2032F

• 4.1. Market Size Analysis & Forecast
  • 4.1.1. By Value
• 4.2. Market Share Analysis & Forecast
  • 4.2.1. By Product
    • 4.2.1.1. Devices
      • 4.2.1.1.1. Near-infrared Fluorescence Imaging Systems
      • 4.2.1.1.2. Near-infrared Fluorescence and Bioluminescence Imaging Systems
    • 4.2.1.2. Reagents
      • 4.2.1.2.1. Indocyanine Green (ICG)
      • 4.2.1.2.2. Other Reagents
  • 4.2.2. By Application
    • 4.2.2.1. Preclinical Imaging
    • 4.2.2.2. Cardiovascular Surgeries
    • 4.2.2.3. Gastrointestinal Surgeries
    • 4.2.2.4. Cancer Surgeries
    • 4.2.2.5. Plastic/Reconstructive Surgeries
    • 4.2.2.6. Others
  • 4.2.3. By End-user
    • 4.2.3.1. Hospitals and Clinics
    • 4.2.3.2. Pharmaceutical and Biotechnology Companies
    • 4.2.3.3. Research Laboratories
  • 4.2.4. By Region
    • 4.2.4.1. North America
    • 4.2.4.2. Central
    • 4.2.4.3. South
  • 4.2.5. By Company Market Share Analysis (Top 5 Companies and Others - By Value, FY2024)
• 4.3. Market Map Analysis, FY2024
  • 4.3.1. By Product
  • 4.3.2. By Application
  • 4.3.3. End-user
  • 4.3.4. By Region

5. Demand Supply Analysis

6. Value Chain Analysis

7. Porter's Five Forces Analysis

8. PESTLE Analysis

9. Pricing Analysis

10. Market Dynamics

• 10.1. Market Drivers
• 10.2. Market Challenges

11. Market Trends and Developments

12. Regulatory Framework and Innovation

• 12.1. Regulatory Approvals
• 12.2. Innovations

13. Patent Landscape

14. Case Studies

15. Competitive Landscape

• 15.1. Competition Matrix of Top 5 Market Leaders
• 15.2. SWOT Analysis for Top 5 Players
• 15.3. Key Players Landscape for Top 10 Market Players
  • 15.3.1. Carl Zeiss Meditec AG
    • 15.3.1.1. Company Details
    • 15.3.1.2. Key Management Personnel
    • 15.3.1.3. Products and Services
    • 15.3.1.4. Financials (As Reported)
    • 15.3.1.5. Key Market Focus and Geographical Presence
    • 15.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisitions
  • 15.3.2. Shimadzu Corporation
  • 15.3.3. Stryker Corporation.
  • 15.3.4. Olympus Corporation.
  • 15.3.5. Hamamatsu Photonics K.K.
  • 15.3.6. Medtronic plc

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

16. Strategic Recommendations

17. About Us and Disclaimer

List of Tables

• Table 1. Pricing Analysis of Products from Key Players
• Table 2. Competition Matrix of Top 5 Market Leaders
• Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. Japan Near-Infrared Imaging Market, By Value, In USD Million, FY2018-FY2032F
• Figure 2. Japan Near-Infrared Imaging Market Share (%), By Product, FY2018-FY2032F
• Figure 3. Japan Near-Infrared Imaging Market Share (%), By Application, FY2018-FY2032F
• Figure 4. Japan Near-Infrared Imaging Market Share (%), By End-user, FY2018-FY2032F
• Figure 5. Japan Near-Infrared Imaging Market Share (%), By Region, FY2018-FY2032F
• Figure 6. By Product Map-Market Size (USD Million) & Growth Rate (%), FY2024
• Figure 7. By Application Map-Market Size (USD Million) & Growth Rate (%), FY2024
• Figure 8. By End-user Map-Market Size (USD Million) & Growth Rate (%), FY2024
• Figure 9. By Region Map-Market Size (USD Million) & Growth Rate (%), FY2024